Ultra Chiron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 24-10-2024
- Paid Up Capital ₹ 2.97 M
as on 24-10-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 M
as on 24-10-2024
- Revenue -41.24%
(FY 2023)
- Profit -13.05%
(FY 2023)
- Ebitda -2.39%
(FY 2023)
- Net Worth 10.44%
(FY 2023)
- Total Assets -5.94%
(FY 2023)
About Ultra Chiron Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.97 M.
The company currently has active open charges totaling ₹1.10 M.
Rajesh Shrivastava, Sanjeev Kumar, Gurmit Singh, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24231CH1993PTC013535
- Company No.
013535
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ultra Chiron Pharmaceuticals Pvt Ltd offer?
Ultra Chiron Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Common Disease Medicines, Pharmaceutical Syrup, Pharma & Bioanalytical Services, PCD Pharma Franchise, Osteoporosis Medications, Nutraceuticals & Dietary Supplements, Health Supplement, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Ultra Chiron Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Managing Director | 20-Jul-1993 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Shrivastava | Director | 16-Aug-2019 | Current |
| Gurmit Singh | Director | 20-Jul-1993 | Current |
| Sadhu Singh | Director | 12-Mar-1999 | Current |
| Mitesh Kumar | Director | 24-Feb-2016 | Current |
| Amrik Singh | Whole-Time Director | 23-Dec-2014 | Current |
| Sudhakar | Director | 11-Sep-2023 | Current |
Financial Performance and Corporate Structure Insights of Ultra Chiron Pharmaceuticals.
Ultra Chiron Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.24% decrease. The company also saw a substantial fall in profitability, with a 13.05% decrease in profit. The company's net worth Soared by an impressive increase of 10.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ultra Chiron Pharmaceuticals?
In 2023, Ultra Chiron Pharmaceuticals had a promoter holding of 99.00% and a public holding of 1.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Preet Remedies LimitedActive 19 years 10 monthsRajesh Shrivastava and Sanjeev Kumar are mutual person
Quixotic Pharma Private LimitedActive 22 years 21 daysRajesh Shrivastava, Sanjeev Kumar and 1 more are mutual person
Oasis Pharma And Phytomolecules Private LimitedActive 17 years 7 monthsSanjeev Kumar is a mutual person
- Ultra Chiron Healthcare Private LimitedActive 20 years 5 months
Sanjeev Kumar and Mitesh Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 10 May 1997 | ₹0.55 M | Open |
Indian Overseas Bank Creation Date: 10 May 1997 | ₹0.55 M | Open |
How Many Employees Work at Ultra Chiron Pharmaceuticals?
Unlock and access historical data on people associated with Ultra Chiron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ultra Chiron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Chiron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
